Rating History for Achillion Pharmaceuticals (ACHN) by UBS

More Stocks Rated by UBS | Latest Ratings for ACHN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/8/2015 N/A Upgrade Buy
(Neutral)		 11.50
(N/A)		 7.74
(0.79)		 -89.79% Details